he world’s first malaria vaccine, produced by GlaxoSmithKline, could be approved by international regulators for use in Africa from October.
The final trial data showed that the shoe, called RTS, S offered partial protection for children for up to four years.
{iframe}http://www.ngrguardiannews.com/2015/04/worlds-first-malaria-vaccine-moves-closer-to-use-in-africa/{/iframe}